Response to Treatment by Multidrug Regimens in the THELEP Controlled Clinical Drug Trials

Leprosy Review - United Kingdom
doi 10.5935/0305-7518.19960027
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

GN1 Genesis Network

Related search

Methodological Considerations in Clinical Trials for New MDR-TB Treatment Regimens

International Journal of Tuberculosis and Lung Disease
MedicinePulmonaryInfectious DiseasesRespiratory Medicine
2016English

Leprosy Treatment in Nepal With Multidrug Regimens

Leprosy Review
DermatologyMedicineInfectious Diseases
1984English

Analysis of Clinical Drug Trials in Children Compared to Clinical Drug Trials in Adults, in Argentina

Archivos Argentinos de Pediatria
Child HealthPediatricsPerinatology
2019English

Revolutionary New Treatment Regimens for Multidrug-Resistant Tuberculosis

The Lancet Infectious Diseases
Infectious Diseases
2019English

Buprenorphine Adoption in the National Drug Abuse Treatment Clinical Trials Network

Journal of Substance Abuse Treatment
MedicineClinical PsychologyPsychiatryPsychiatric Mental HealthMental Health
2009English

Evaluating Duration of Response to Treatment in Systemic Lupus Erythematosus Clinical Trials

Lupus Science and Medicine
MedicineImmunology
2018English

Final Treatment Outcomes of Multidrug- And Extensively Drug-Resistant Tuberculosis Patients in Latvia Receiving Delamanid-Containing Regimens

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2017English

An Optimized Background Regimen Design to Evaluate the Contribution of Levofloxacin to Multidrug-Resistant Tuberculosis Treatment Regimens: Study Protocol for a Randomized Controlled Trial

Trials
MedicinePharmacology
2017English

Investigation of Drug Interactions by Clinical Studies^|^frasl;Trials

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy